Skip to main content
GutCited
Figure 3

विवरण

Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes.

Figure 3

Chart
797 × 1338px · 285.7 केबी 

Source Paper

Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease.

Neurogastroenterology and motility (2020)

PMID: 32476236

DOI: 10.1111/nmo.13914

Cite This Figure

![Figure 3: Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes.](https://pdfs.citedhealth.com/figures/32476236/609.png)

> Source: Sonia Facchin et al. "Microbiota changes induced by microencapsulated sodium butyrate in patients with." *Neurogastroenterology and motility*, 2020. PMID: [32476236](https://pubmed.ncbi.nlm.nih.gov/32476236/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/32476236/609.png" alt="Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes." />
  <figcaption>Figure 3. Beta diversity analysis using principal coordinates reveals shifts in overall microbiota community structure following butyrate supplementation. Separation between pre- and post-treatment samples suggests reproducible compositional changes.<br>  Source: Sonia Facchin et al. "Microbiota changes induced by microencapsulated sodium butyrate in patients with." <em>Neurogastroenterology and motility</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32476236/">32476236</a></figcaption>
</figure>